FDA Inspection 1210350 — Sara Lonardi
The FDA completed an inspection of Sara Lonardi on June 23, 2023 in Padova. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 23, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Padova (Italy)
Additional Details
Clinical Investigator (CI)